RapidAI

What is RapidAI?

RapidAI offers a comprehensive clinical platform designed to improve diagnosis, treatment, and management of stroke and neurovascular conditions. Its suite of FDA-cleared modules provides automated analysis of CT and MRI scans, enabling faster and more accurate detection of anomalies such as large vessel occlusions and aneurysms. By integrating seamlessly into healthcare workflows, RapidAI supports multidisciplinary teams with actionable insights, enhancing patient outcomes and operational efficiency across hospitals worldwide.

Key Features

• Deep Clinical Imaging Analysis

  Automated processing of CT and MRI scans to identify and quantify stroke-related anomalies including large vessel occlusions, hemorrhages, and aneurysms.

• Real-Time Results Delivery

  Instant notification and visualization of critical findings accessible via mobile apps, PACS, and integrated hospital systems for rapid clinical decision-making.

• Comprehensive Stroke Workflow Support

  Tools that streamline triage, treatment eligibility assessment, and longitudinal tracking to optimize patient care pathways and resource allocation.

• Enterprise-Grade Scalability

  Platform designed for deployment across multiple hospitals and service lines, supporting cross-disciplinary collaboration and consistent clinical standards.

• Regulatory-Cleared Modules

  Includes 14 FDA-cleared imaging modules with extensive clinical validation and backed by numerous publications and trials.

Use Cases

• Stroke Diagnosis and Management : Accelerate identification and treatment decisions for ischemic and hemorrhagic strokes using automated imaging analysis and real-time alerts.
• Neurovascular Anomaly Detection : Enhance detection of subtle aneurysms and vascular abnormalities to improve diagnostic confidence and patient outcomes.
• Workflow Optimization in Radiology : Streamline imaging review and reporting processes, reducing time to intervention and improving coordination among care teams.
• Clinical Trials and Research : Support patient enrollment and data quality for life sciences studies with precise imaging biomarkers and tracking capabilities.

FAQs